DuPont announced it has reached a definitive agreement to divest its Aramids business, including Kevlar and Nomex, to Arclin, a portfolio company of an affiliate of TJC, L.P. (TJC), in a transaction valuing the business at approximately $1.8 billion. The deal is expected to close in the first quarter of 2026, pending regulatory approvals and customary conditions.
At closing, DuPont will receive pre-tax cash proceeds of approximately $1.2 billion, a $300 million note receivable, and a non-controlling equity stake in the new Arclin company valued at $325 million, representing an estimated 17.5% ownership.
"Today's announcement is another important step in our continued optimization of the new DuPont portfolio," said Lori Koch, CEO of DuPont. "The transaction enhances our portfolio's growth and margin profile, provides significant upfront cash to drive shareholder value, and retains upside potential through our equity interest in Arclin."
Arclin's President and CEO Bradley Bolduc called the acquisition a transformative move: "The addition of Kevlar and Nomex presents a unique opportunity to expand our scale, global reach, and innovation capabilities. Together, we will continue to deliver impactful solutions that protect people and critical infrastructure worldwide."
DuPont's Aramids business, with 1,900 employees and five manufacturing sites, generated $1.3 billion in sales in 2024 and remains the global leader in high-performance synthetic fibers. The divestiture will not affect DuPont's planned spin-off of its electronics unit, Qnity, which remains on track for November 1, 2025.
Source: www.dupont.com
